We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

Two orange pill bottles next to a model of a human brain and a doctor writing on a clipboard.

Mutation Linked to Epilepsy Targeted With Novel Gene Therapy

A doctor holding a clipboard.

Gene Therapy Shows Long-Term Benefit for Rare Pediatric Brain Disease

A palm outstretched containing plastic pieces.

When Microplastics Cross the Placenta, They Remain in Neonatal Tissue

Unlocking Drug Delivery to the Brain With Microbubbles and Ultrasound

IV Medicines Could Be Turned Into Pills With New Strategy

Cancer Drug Acts Differently Across Different Cancer Types

News

Angiotech Announces Drug Discovery And Development Agreement with CombinatoRx

The agreement provides Angiotech with immediate access to CombinatoRx's combination pharmaceutical compounds.

NIH Renews Its Pharmacogenetics Research Network

The NIH anticipates spending $150 million over five years to renew its Pharmacogenetics Research Network.

Effectiveness of Drug Screening System Utilizing Active Learning

NEC has announced that it has verified the effectiveness of the drug screening system, ChemMiner™.

Celliance Acquires Gene Expression Technology

The UCOE technology will augment Celliance’s cell line development and protein expansion capabilities.

Chemicon and Axordia to Co-Develop Antibody Markers

Axordia will contribute proprietary expertise and materials for antibody generation and antibody characterization.

AstraZeneca Chooses Aitken Scientific software

The software will help to track samples and control the workflow in a substantial project to increase AstraZeneca’s high throughput purification capacity.

Icoria Receives Notice of Allowance on Tissue Analysis Patent

Allowed patent covers measurement of several tissue structure features for high-throughput screening.

Provid Announces National Cancer Institute Contract

Provid will apply its hypothesis-driven drug discovery chemistry to translate the assay hits into viable drug candidate leads for applications in cancer therapy.

Strand and Elan Enter Into Research Collaboration

This collaboration allows Elan to access Strand's technologies and achieve customized solutions for internal research programs.

Qiagen Delivers the Human Druggable Genome siRNA Set

This second generation siRNA set enables gene silencing studies of 6992 potential human druggable targets.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter